Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Income Statement [Abstract]    
Revenues $ 2,082,950 $ 1,150,719
Cost of revenues, including depreciation 888,869 471,068
Gross profit 1,194,081 679,651
Operating expenses:    
Personnel 184,671 167,862
Marketing and promotion 51,761 69,469
General and administrative 706,483 213,768
Total operating expenses 942,915 451,099
Operating income 251,166 228,552
Non-operating expenses:    
Interest expense, net 296,427 81,592
Equity compensation 572,807 19,295
Loss on debt settlements (1,213,841) (18,278)
Total non-operating expenses 2,083,075 119,165
Net income (loss) (1,831,909) 109,387
Net income (loss) to noncontrolling interests 63,233 141,626
Net income (loss) attributable to MariMed Inc. $ (1,895,142) $ (33,240)
Net income (loss) per share $ (0.011) $ (0.001)
Weighted average common shares outstanding 178,914,829 64,208,389